Consensus Premier, Inc.

Equities

PINC

US74051N1028

Market Closed - Nasdaq Other stock markets 04:00:02 2024-04-23 pm EDT			5-day change	1st Jan Change
21.03 ^USD	-0.10%		+1.59%	-5.95%

Apr. 09	Empire Genomics Corp. Wins Molecular Analyzers, Reagents Agreement with Premier, Inc	CI
Mar. 12	Transcript : Premier, Inc. Presents at Barclays 26th Annual Global Healthcare Conference 2024, Mar-12-2024 02:05 PM

Evolution of the average Target Price on Premier, Inc.

Price target over the last 5 years

History of analyst recommendation changes

eabff9dd1db85e80e.UNywWIS1ByJhr1VPXytOneTPcyr5_Olsn0KiOBcYJzs.IuqJD-vASE8omiYtEx09zIOFFl-LlZldxwPEWSVHFHg26vdrtIBQTS7_YQ~efa0b7fa0ec9df608806fb7eaa607233

Analyst Recommendations on Premier, Inc.

Leerink Partners Initiates Coverage on Premier With Market Perform Rating, $22.50 Price Target	Feb. 26	MT
UBS Adjusts Premier Price Target to $22 From $21, Maintains Neutral Rating	Feb. 07	MT
North American Morning Briefing : Rate Doubts Keep -2-	Feb. 06	DJ
JPMorgan Cuts Price Target on Premier to $21 From $26, Maintains Neutral Rating	Nov. 13	MT
Benchmark Adjusts Price Target on Premier to $30 From $32, Maintains Buy Rating	Nov. 09	MT
Baird Adjusts Premier's Price Target to $24 From $30, Keeps Neutral Rating	23-08-24	MT
Nephron Research Adjusts Premier's Price Target to $28 From $31, Keeps Hold Rating	23-08-23	MT
UBS Adjusts Premier Price Target to $26 From $29, Maintains Neutral Rating	23-08-23	MT
Benchmark Adjusts Premier's Price Target to $32 From $37, Keeps Buy Rating	23-08-23	MT
BofA Securities Adjusts Premier's Price Target to $26 From $31, Keeps Underperform Rating	23-08-23	MT
Canaccord Genuity Adjusts Premier's Price Target to $30 From $38, Keeps Buy Rating	23-08-23	MT
Piper Sandler Downgrades Premier to Neutral From Overweight, Adjusts Price Target to $25 From $44	23-08-23	MT
ANALYST RECOMMENDATIONS : Brown-Forman, Dick's Sporting Goods, Dollar General, Lowe's, United Utilities...	23-08-23
Credit Suisse Lowers Premier's Price Target to $33 From $37, Keeps Neutral Rating	23-05-08	MT
UBS Adjusts Premier Price Target to $29 From $36, Maintains Neutral Rating	23-05-04	MT
Baird Downgrades Premier to Neutral From Outperform, Adjusts Price Target to $30 From $43	23-05-03	MT
Raymond James Downgrades Premier to Market Perform From Outperform	23-05-03	MT
ANALYST RECOMMENDATIONS : Ashtead, Bunzl, Molson Coors, Roper...	23-05-03
Baird Adjusts Price Target on Premier to $43 From $42, Maintains Outperform Rating	23-04-18	MT
SVB Securities Adjusts Price Target on Premier to $42 From $46, Maintains Outperform Rating	23-02-08	MT
Credit Suisse Upgrades Premier to Neutral From Underperform on Fairer Balance of Favorable Trends, Downside Risks; Keeps $38 Price Target	23-01-27	MT
JPMorgan Chase Adjusts Price Target on Premier to $30 From $41, Maintains Neutral Rating	22-11-18	MT
UBS Adjusts Premier Price Target to $36 From $40, Maintains Neutral Rating	22-11-03	MT
Baird Upgrades Premier to Outperform From Neutral With $41 Price Target	22-11-02	MT
ANALYST RECOMMENDATIONS : BAT, Microsoft, NXP Semi, Snowflake, Clorox...	22-11-02

More recommendations

Analysts' Consensus

Sell

Buy

Mean consensus

HOLD

Number of Analysts

Last Close Price

21.03 USD

Average target price

24.28 USD

Spread / Average Target

+15.44%

High Price Target

30 USD

Spread / Highest target

+42.65%

Low Price Target

21 USD

Spread / Lowest Target

-0.14%

Consensus detail

Consensus revision (last 18 months)

Analysts covering Premier, Inc.

Leerink Partners
UBS
JPMorgan Chase
Benchmark Company
Baird
Nephron Research
BofA Securities
Canaccord Genuity
Piper Sandler
Credit Suisse
Raymond James
SVB Securities LLC
Guggenheim
Barclays
Berenberg Bank
SVB Leerink
Benchmark Capital

Ratings for Premier, Inc.

Trading Rating

Investor Rating

ESG Refinitiv

B-

More Ratings

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar